Navigation Links
Lymphoma Research Foundation announces recipients of CLL/SLL Research Initiative grants
Date:10/28/2009

New York, NY The Lymphoma Research Foundation (LRF) is pleased to announce that David Frank, MD, PhD of the Dana-Farber Cancer Institute and Thomas Kipps, MD, PhD, Moores Cancer Center, University of California, San Diego are the recipients of the second round of funding under the Foundation's Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Research Initiative.

Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) are the same disease with slightly different manifestations. Where the cancerous cells gather determines whether it is called CLL or SLL. When the cancer cells are primarily found in the lymph nodes, lima bean shaped structures of the lymphatic system, an essential part of the body's immune system, it is called SLL. When most of the cancer cells are in the bloodstream and the bone marrow, it is called CLL.

John Balan, founder of the CLL Information Group with membership of approximately 1000 patients and caregivers, expressed the group's delight with these two awards. "We have a great deal of respect for the work that Drs. Kipps and Frank have been doing with CLL. These two awards will only augment what they have already done and add to the arsenal of treatments available to patients."

The purpose of Dr. Frank's, A Clinical Trial of STAT3 Inhibition in Patients with CLL, will be to evaluate the benefits of targeted therapy for CLL/SLL patients. Through prior research, Dr. Frank and his team found that CLL/SLL cells are characterized by an abnormality in a protein called STAT3, which regulates genes controlling the abnormal proliferation of lymphocytes in patients with this disease. They further identified a drug that inhibits STAT3, and, with the two-year $300,000 grant from LRF, Dr. Frank will carry out a clinical trial to test its safety and effectiveness in CLL/SLL patients. This is Dr. Frank's second LRF grant supporting his efforts to discover more effective CLL/SLL ther
'/>"/>

Contact: Marion F. Swan
mswan@lymphoma.org
347-920-6680
Lymphoma Research Foundation
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
2. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
3. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
4. January 1 Looms Large for Lymphoma Patients
5. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
6. Possible Cure for Rare Lymphoma Reported
7. Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting
8. Gentler chemotherapy before stem cell transplant causes long-term remission of follicular lymphoma
9. Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
10. Lymphoma drug used to treat skin disorders
11. Firefly genes allow testing of new therapy against lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lymphoma Research Foundation announces recipients of CLL/SLL Research Initiative grants
(Date:5/4/2015)... DC (PRWEB) May 04, 2015 ... has just released the first-ever congenital heart ... Cardiac Catheterization Laboratory (PCCL) accreditation. Driven by ... standards are a comprehensive review of interventional ... congenital heart disease. , “The ACE CHD ...
(Date:5/4/2015)... Sara Soulati, CEO of Global Cardio ... Los Angeles associated with the field of Enhanced External ... Sara Soulati Health For Life Program (SSHFLP). , The ... modification and disease prevention program. A provisional patent ... Patents and Trademarks Office and is now under review ...
(Date:5/3/2015)... ANGELES, American Telemedicine Association 2015 Meeting & Tradeshow ... e-health solutions, a full-service telemedicine and mobile health ... new platform, VITA health services for chronic disease ... services platform enables remote patient monitoring of a ... heart failure (CHF), diabetes, COPD, hypertension and other ...
(Date:5/3/2015)... “ BolehVPN ” was featured on NewsWatch ... latest and coolest technology products available to consumers. Scott Steinberg, ... review and shared with viewers how to protect their private ... is on computers and even more so online. It helps ... all over the world. In terms of work, the internet ...
(Date:5/3/2015)... It is not too late to register to take part ... Lissa Anne Been in Arnold, Missouri on May 9, 2015. ... honor her loving memory. It has benefited the renowned Brain Aneurysm ... 37, Lissa suffered a brain aneurysm . After two operations ... event is designed to serve as a remembrance of her and ...
Breaking Medicine News(10 mins):Health News:Accreditation for Cardiovascular Excellence (ACE) Publishes New Standards for Pediatric and Adult Congenital Cardiac Catheterization Laboratories 2Health News:CEO Sara Soulati Announces Patent-Pending Designation For The Sara Soulati Health For Life Program 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 3Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2
... not invincible but its weaknesses can be difficult to detect. ... Greek warrior whose one vulnerability led to his undoing ... weak spots. In their largest and most comprehensive effort to ... and the Dana-Farber Cancer Institute examined cells from over 100 ...
... University College of Engineering student, has received the 2011 ... program financially supports scientific studies that investigate and aim ... a Ph.D. student under the supervision of Sean Wu, ... is developing an innovative, 3-D computer-aided diagnostic system to ...
... CITY One-fifth of all patients with pulmonary arterial ... two years before being correctly diagnosed and properly treated, ... at Intermountain Medical Center in Salt Lake City. ... is more difficult and the damage is irreversible," said ...
... stroke Stroke is a leading cause of long-term ... researchers led by Gregory Bix, at Texas A&M College ... exploit one of the brain,s self-repair mechanisms to protect nerve ... The authors suggest that this approach could provide a nontoxic ...
... changes in the structure of DNA so-called epigenetic ... cells, according to one of two studies conducted by ... Cancer Institute. Together with collaborators from a biotechnology company, ... that blocks these changes could deactivate cancer-promoting genes and ...
... are physically active and eat plenty of vegetables but few ... study led by researchers at the Keck School of Medicine ... published in the July 2011 issue of the American ... to examine how weight among Chinese adolescents relates to factors ...
Cached Medicine News:Health News:Project Achilles pinpoints vulnerabilities in ovarian cancer 2Health News:Project Achilles pinpoints vulnerabilities in ovarian cancer 3Health News:New study may lead to quicker diagnosis, improved treatment for fatal lung disease 2Health News:JCI online early table of contents: July 11, 2011 2Health News:JCI online early table of contents: July 11, 2011 3Health News:JCI online early table of contents: July 11, 2011 4Health News:JCI online early table of contents: July 11, 2011 5Health News:JCI online early table of contents: July 11, 2011 6Health News:JCI online early table of contents: July 11, 2011 7Health News:JCI online early table of contents: July 11, 2011 8Health News:Epigenetic pathway and new drug show promise in reversing a hard-to-treat childhood cancer 2Health News:Epigenetic pathway and new drug show promise in reversing a hard-to-treat childhood cancer 3Health News:'Healthy' habits linked to childhood obesity in China 2Health News:'Healthy' habits linked to childhood obesity in China 3
(Date:5/4/2015)... 2015   Mallinckrodt plc (NYSE: MNK ), ... 13, 2015, at the Bank of America Merrill Lynch 2015 ... Las Vegas, Nev. ... Officer, and Cole Lannum , Senior Vice President of ... in a session scheduled to begin at 3 p.m. Eastern ...
(Date:5/4/2015)... Colo., May 4, 2015  Array BioPharma Inc. ... the third quarter of its fiscal year ending ... Executive Officer of Array, noted, "With the close of ... and encorafenib, two innovative oncology products in Phase ... product in 2016. These transformative transactions have accelerated ...
(Date:5/4/2015)... HAVEN, Conn. , May 4, 2015 /PRNewswire/ ... chosen by the American Optometric Association (AOA) to ... delivery and outcomes for the millions of patients ... Measures and Outcomes Registry for Eyecare (MORE) ... will securely facilitate efficient secondary uses of essential ...
Breaking Medicine Technology:Mallinckrodt To Present At Bank Of America Merrill Lynch 2015 Health Care Conference 2Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 10American Optometric Association, Prometheus Research to Create Transformative Health Outcomes Registry 2
... The next generation Powerheart AED has ... our flagship, feature-rich AED offering. The ... new customer-friendly features such as more ... new lighter weight, redesigned form factor, ...
... Plus™ is the best EMR value for ... in mind, Charting Plus™ relies heavily on ... features to improve documentation quality and increase ... content is specific to your medical specialty. ...
... the vast information needs of orthopedics specialty. ... for common orthopedics complaints, history of present ... also includes orthopedics specific ICD and CPT ... charges and quickly generate electronic Superbill at ...
... Maximo, Model 7303, incorporates new advances in CRT ... Proven Marquis ICD Platform. With this device, ... in 9 seconds or less throughout the life ... (14% increase in longevity over InSync II Marquis) ...
Medicine Products: